Post by argenx

Advances in our understanding of FcRn have helped reshape how HCPs treat IgG-mediated autoimmune diseases.   In this article with our partners at Scientific American Custom Media, leading scientists including argenx’ Chief Scientific Officer Peter Ulrichts reflect on:   🔬 New insights into how FcRn functions — and how those insights helped advance autoimmune research 💡 The development of precision approaches for reducing harmful autoantibodies 🤝 How co-creation through argenx' Immunology Innovation Program (IIP) helps translate scientific discovery into meaningful impact for patients   Read the article here: https://bit.ly/44idQo4   #TogetherWeDiscover